GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » Beta

WIN-Partners Co (TSE:3183) Beta : 0.22 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-21), WIN-Partners Co's Beta is 0.22.


WIN-Partners Co Beta Historical Data

The historical data trend for WIN-Partners Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co Beta Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 1.00 1.01 0.80 0.32

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.32 0.27 0.24 0.19

Competitive Comparison of WIN-Partners Co's Beta

For the Medical Distribution subindustry, WIN-Partners Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's Beta Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Beta distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's Beta falls into.



WIN-Partners Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


WIN-Partners Co  (TSE:3183) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


WIN-Partners Co Beta Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines